46) Mizuki Horiuchi, Soichiro Moriyama, Yukiko Takahata, Tetsuya Aiba and Yuji Kurosaki:
Effects of peritoneal dialysis on pharmacotherapy: A deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid.
Drug Metab. Pharmacokinet., 29 (2), 154-161 (2014 Apr).



45) Ayumi Masuda, Yuko Goto, Yuji Kurosaki and Tetsuya Aiba:
In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
J. Pharm. Sci., 101 (7), 2449-2456 (2012 Jul).

44) 黒崎勇二、富岡佳久、三田智文、北村佳久 (Yuji Kurosaki, Yoshihisa Tomioka, Tomofumi Santa and Yoshihisa Kitamura)：
（総説）国立大学における「長期課題研究及びアドバンスト教育プログラム」の現状 [(Review) Development of advanced educational programs including research programs for undergraduate students in National Universities: the facts in 2010].，
Yakugaku Zasshi, 132 (3), 351-356 (2012 Mar).

43) Junichi Kusaba, Noriko Kajikawa, Hiromu Kawasaki, Yuji Kurosaki and Tetsuya Aiba:
Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 33 (1), 22-29 (2012 Jan).



42) Shinsuke Inoue, Tetsuya Aiba, Yasuyuki Masaoka, Keiko Shimizu, Yukiko Komori, Mitsunobu Mio, Shingo Takatori, Hiromu Kawasaki and Yuji Kurosaki:
Pharmacodynamic characterization of nitric oxide-mediated vasodilatory activity in isolated perfused rat mesenteric artery bed.
Biol. Pharm. Bull., 34 (9), 1487-1492 (2011 Sep).

41) Akemi Ogasawara, Yoshiki Murakami, Nobumasa Yakushiji, Fuminori Ohsawa, Jun-ichi Kusaba, Tetsuya Aiba, Yuji Kurosaki and Hiroki Kakuta:
Pharmacokinetic properties of newly synthesized retinoid X receptor agonist possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats.
Drug Develop. Ind. Pharm., 37 (9), 1060-1067 (2011 Sep).

40) Satoshi Ueshima, Tetsuya Aiba, Tomoaki Sato, Hisashi Matsunaga, Yuji Kurosaki, Yoko Ohtsuka, Toshiaki Sendo:
Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development.
Biol. Pharm. Bull., 34 (1) 108-113 (2011 Jan).



39) Atsuko Ishikawa, Kentaro Kono, Rie Sakae, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Altered electrolyte handling of the choroid plexus in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 31 (8-9), 455-463 (2010 Nov).

38) Naomi Iihara, Kiyo Suzuki, Yuji Kurosaki, Shushi Morita, Keizo Hori:
Factorial invariance of a questionnaire assessing medication beliefs in Japanese non-adherent groups.
Pharmacy World Sci., 32 (4), 432-439 (2010 Aug).

37) Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, Katsuya Suemaru, Tatsuya Nishimiya, Tomoyoshi Inoue, Mitsuharu Murase, Yuji Kurosaki and Hiroaki Araki:
Population pharmacokinetic analysis of vancomycin using serum cystatin-C as a marker of renal function.
Antimicrob. Agents Chemother., 54 (2), 778-782 (2010 Feb).



36) S. Ueshima, T. Aiba, N. Ishikawa, T. Sato, H. Kawasaki, Y. Kurosaki, Y. Ohtsuka and T. Sendo:
Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
J. Clin. Pharm. Ther., 34 (4), 415-422 (2009 Aug).

35) Yuki Izuwa, Jun-ichi Kusaba, Mizuki Horiuchi, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
Drug Metab. Pharmacokinet., 24 (5), 451-457 (2009 May).

34) Takashi Makita, Tetsuya Aiba, Yuki Izuwa, Yukiko Komori, Hiromu Kawasaki and Yuji Kurosaki:
Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
Biopharm. Drug Dispos., 30 (1), 1-8 (2009 Jan).



33) 出羽祐基，上島　智，佐藤智昭，岡崎昌利，合葉哲也，川﨑博己，黒﨑勇二，千堂年昭 (Yuki Izuwa, Satoshi Ueshima, Tomoaki Sato, Masatoshi Okazaki, Tetsuya Aiba, Hiromu Kawasaki, Yuji Kurosaki and Toshiaki Sendo)：
注射用塩酸バンコマイシン製剤の先発品及び後発品による腎機能低下事例の発症状況の比較，
[Frequency of decreased renal function between patients treated with brand and generic products of vancomycin hydrochloride injection].
Yakugaku Zasshi, 128 (10), 1493-1498 (2008 Oct).

32) Rie Sakae, Atsuko Ishikawa, Tomoko Niso, Yukiko Komori, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Decreased Lithium Disposition to Cerebrospinal Fluid in Rats with Glycerol-induced Acute Renal Failure.
Pharm. Res., 25 (10), 2243-2249 (2008 Oct).

31) Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake and Shushi Morita:
Changes in attitudes among Japanese patients after Pharmacist Law revision.
Pharmacy World Sci., 30 (3), 258-264 (2008 Jun).

30) Zen-ichi Masuda, Yuji Kurosaki, Kozo Ishino, Keita Yamauchi, Shunji Sano:
Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration.
General Thoracic Cardiovasular Surgery, 56 (4), 163-169 (2008 Apr).

29) Satoshi Ueshima, Tetsuya Aiba, Takashi Makita, Shigeki Nishihara, Yoshihisa Kitamura, Yuji Kurosaki, Hiromu Kawasaki, Toshiaki Sendo, Yoko Ohtsuka and Yutaka Gomita:
Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
J. Clin. Pharm. Ther., 33 (1), 31-38 (2008 Feb).

28) Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake, Shushi Morita and Keizo Hori:
Comparison of individual perceptions of medication costs and benefits
between intentional and unintentional medication non-adherence among
Japanese patients.
Patient Education Counseling, 70 (2), 292-299, (2008 Feb).

27) Naomi Iihara, Yuji Kurosaki, Mitsutaka Takada and Shushi Morita:
Risk of hypoglycemia associated with thyroid agents is increased in patients with liver impairment.
Int. J. Clin. Pharmacol. Ther., 46 (1), 1-13, (2008 Jan).



26) Yukiko Komori, Tetsuya Aiba, Chie Nakai, Risa Sugiyama, Hiromu Kawasaki and Yuji Kurosaki:
Capsaicin-induced increase of intestinal cefazolin absorption in rats.
Drug Metabol. Pharmacokinet., 22 (6), 445-449 (2007 Dec).

25) Hidekatsu Nishimura, Chiaki Hayashi, Tetsuya Aiba, Ichiro Okamoto, Yuji Miyamoto, Susumu Nakade, Kazuhisa Takeda, Yuji Kurosaki:
Application of the correlation of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for soft-gel capsules － A pointless pursuit?
Biol. Pharm. Bull., 30 (11), 2221-2225 (2007 Nov).

24) Yuji Kurosaki, Masahiro Tagawa, Akiho Omoto, Hiroshi Suito, Yukiko Komori, Hiromu Kawasaki and Tetsuya Aiba:
Evaluation of intramuscular lateral distribution profile of topically administered acetaminophen in rats.
Int. J. Pharm., 343 (1-2), 190-195 (2007 Oct).

23) 土居智明，飯原なおみ，河添　仁，福岡憲泰，芳地　一，黒崎勇二，森田修之 (Chiaki Doi, Naomi Iihara, Hitoshi Kawazoe, Noriyasu Hukuoka, Hajime Houchi, Yuji Kurosaki, Shusi Morita)：
個々の患者の副作用予測のために開発された婦人科がん化学療法モニタリングシート.
[Monitoring sheet covering long-term chemotherapy to predict individual adverse reaction patterns for patients with gynecologic chemotherapy].
Yakugaku Zasshi，127 (6), 1027-1033 (2007 Jun).

22) Yukiko Komori, Tetsuya Aiba, Risa Sugiyama, Chie Nakai, Hiromu Kawasaki and Yuji Kurosaki:
Effect of capsaicin on intestinal cephalexin absorption in rats.
Biol. Pharm. Bull., 30 (3), 547-551 (2007 Apr).

21) Yukiko Komori, Tetsuya Aiba, Miki Kushima, Hiromu Kawasaki and Yuji Kurosaki:
Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
J. Pharm. Sci., 96 (4), 935-943 (2007 Mar).







Tetsuya Aiba, Mizuki Horiuchi, Takashi Makita, Yukiko Komori, Hiromu Kawasaki and Yuji Kurosaki:
Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure.
Drug Metabol. Pharmacokinet., 21 (4), 291-296 (2006 Aug).

Hiroo Maeda, Toshihiko Sugie, Akihiko Sano, Hiromu Kawasaki and Yuji Kurosaki:
Study on accelerated evaluation system for release profiles of covered-rod type silicone formulation using indomethacin as a model drug.
J. Controlled Release, 94 (3), 337-349 (2004 Feb).

Hiroo Maeda, Erika Ohashi, Akihisa Sano, Hiromu Kawasaki and Yuji Kurosaki:
Investigation of release behavior of covered-rod type formulation using silicone.
J. Controlled Release, 90 (1), 59-70 (2003 Jun).

Keita Yamauchi, Shoji Yasunaga, Hiromu Kawasaki and Yuji Kurosaki:
An approach to predict the ductus-arteriosus dilating effect induced by lipo-prostaglandin E1 in newborn rats lacking plasma concentration-time data by the pharmacological response kinetic model.
Biol. Pharm. Bull., 26 (2), 210-215 (2003 Feb).